Publication: The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID: Overview Report
dc.contributor.author | Wang,Huihui | |
dc.contributor.author | Marquez,Patricio V. | |
dc.contributor.author | Figueras Sune,Albert-Jesus | |
dc.contributor.author | Kseniya Bieliaieva | |
dc.date.accessioned | 2023-08-15T20:41:51Z | |
dc.date.available | 2023-08-15T20:41:51Z | |
dc.date.issued | 2023-08-15 | |
dc.description.abstract | Although indispensable for improving health outcomes, medicines and vaccines or their administration and use can produce adverse effects, requiring continuous vigilance to ensure that the benefits outweigh the risks. Monitoring the safety of the use of marketed medicines and vaccines, also known as pharmacovigilance, should therefore become much more explicit in efforts to strengthen health systems and prepare for public health crises and normal times because the world is determined to build back better after the COVID-19 pandemic. The objective of this report is to examine the importance of pharmacovigilance in a health system both during a health crisis and in normal times, describe the function, structure, and processes of a functional pharmacovigilance system, and explain the value of drug safety monitoring in building resilience in health systems post-COVID-19 pandemic. | en |
dc.identifier | http://documents.worldbank.org/curated/en/099605308102348301/IDU0890f29d00da80040be092160c2b923396f49 | |
dc.identifier.doi | 10.1596/40205 | |
dc.identifier.uri | https://openknowledge.worldbank.org/handle/10986/40205 | |
dc.language | English | |
dc.language.iso | en | |
dc.publisher | World Bank, Washington, DC | |
dc.relation.ispartofseries | Pharmacovigilance and Essential Public Health Services Series | |
dc.rights | CC BY-NC 3.0 IGO | |
dc.rights.holder | World Bank | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/3.0/igo | |
dc.subject | PUBLIC HEALTH RISK RESPONSE | |
dc.subject | HEALTH SYSTEMS | |
dc.subject | COVID-19 PANDEMIC RESPONSE | |
dc.subject | EMERGING DISEASE CHALLENGE | |
dc.subject | PUBLIC HEALTH SURVEILLANCE | |
dc.subject | SEASONAL EPIDEMIC INFECTION | |
dc.subject | NATIONAL HEALTH SURVEILLANCE SYSTEM | |
dc.subject | PHARMACOVIGILANCE | |
dc.subject | KOREA-WORLD BANK PARTNERSHIP FACILITY (KWPF) | |
dc.subject | CHINA-WORLD BANK PARTNERSHIP TRUST FUND (CWPF) | |
dc.title | The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID | en |
dc.title.subtitle | Overview Report | en |
dc.type | Report | |
dspace.entity.type | Publication | |
okr.crossref.title | The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID: Overview Report | |
okr.date.disclosure | 2023-08-10 | |
okr.date.lastmodified | 2023-08-10T00:00:00Z | en |
okr.doctype | Report | |
okr.doctype | Publications & Research | |
okr.docurl | http://documents.worldbank.org/curated/en/099605308102348301/IDU0890f29d00da80040be092160c2b923396f49 | |
okr.guid | 099605308102348301 | |
okr.identifier.docmid | IDU-890f29d0-da80-40be-9216-c2b923396f49 | |
okr.identifier.doi | http://dx.doi.org/10.1596/40205 | |
okr.identifier.externaldocumentum | 34133699 | |
okr.identifier.internaldocumentum | 34133699 | |
okr.identifier.report | 184486 | |
okr.import.id | 1490 | |
okr.imported | true | en |
okr.language.supported | en | |
okr.pdfurl | http://documents.worldbank.org/curated/en/099605308102348301/pdf/IDU0890f29d00da80040be092160c2b923396f49.pdf | en |
okr.sector | Health-HG | |
okr.theme | Health Systems and Policies,Human Development and Gender,Private Sector Delivery in Health,Reproductive and Maternal Health,Health Finance,Health Service Delivery,Health System Strengthening,Child Health,Adolescent Health,Health Systems and Policies,Human Development and Gender,Disease Control,Health System Strengthening,Pandemic Response,Health Service Delivery | |
okr.topic | Health, Nutrition and Population::Public Health Promotion | |
okr.topic | Health, Nutrition and Population::Health Systems Development & Reform | |
okr.topic | Health, Nutrition and Population::Pharmaceuticals & Pharmacoeconomics | |
okr.unit | HNP Global (HHNGE) |
Files
License bundle
1 - 1 of 1